Dr. Joseph A. Balsamo, MD

Dr. Balsamo practices at HHC Physician Services in West Haven, Connecticut.

Dr. Balsamo's NPI, 1487650222, was assigned on June 27, 2005. Dr. Balsamo graduated from Universidad del Noreste in 1986. Dr. Balsamo holds Connecticut license 031839.

Dr. Balsamo's primary practice is HHC Physician Services, at 1 Cellini Pl, West Haven, CT 06516 in South Central Ct County. The practice phone is (203) 488-7228.

Dr. Balsamo's primary practice is HHC Physician Services in West Haven, Connecticut. Dr. Balsamo is also affiliated with Yale New Haven Hospital. The medical group on file is Physicians Alliance of Connecticut (PACT). Dmand AI also links Dr. Balsamo to 3 more hospitals, 5 hospices, 4 home health agencies, 3 skilled nursing facilities, 1 group practice or clinic, 1 therapy and rehab clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Balsamo practices, 18 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Balsamo's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Balsamo is licensed in Connecticut.

CMS data shows 629 Medicare services from Dr. Balsamo across 11 procedure codes in 2024, for 288 Medicare patients. Medicare paid $51,141 for them.

CMS counts 288 Medicare patients who saw Dr. Balsamo in 2024. The largest group is 75 to 84, with 102 patients. 75% of them have high blood pressure, and 72% have high cholesterol. 26% are also on Medicaid. Their average risk score is 1.72, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Balsamo's median patient age at 72, with 49% women.

In 2024, Dr. Balsamo wrote 17,176 Medicare Part D claims for 945 patients. 87% of them were for generic drugs. CMS names the drug for 16,238 of them, across 214 drugs with 11 or more claims each, at $1,145,802 in total drug cost. In 2023, CMS named 19,811 claims across 228 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 95 out of 100 for Dr. Balsamo for performance year 2024, reported as part of a group. Dr. Balsamo accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Balsamo as offering telehealth.

Dmand AI links 6 papers to Dr. Balsamo, published from 2019 to 2024. 2024 was the busiest year, with 2. The most frequent topics are Biological Products, Histones and Metabolomics. Dr. Balsamo's most frequent co-authors are Kevin Bersell, MD, PhD, Cheng Her, MD and Zhentao Zhang, MD, PhD.

CMS Open Payments shows 95 general payments to Dr. Balsamo from 24 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 87% of the total. Merck Sharp & Dohme Corporation paid the most, $253.

Dr. Balsamo graduated from Universidad del Noreste in 1986.